Abstract
Increased tendency of cancer patient to develop venous thromboembolism (VTE) is associated with high rates of mortality. Elevation of procoagulant proteins and down regulation of naturally occurring coagulation inhibitors appears to form the basis of high risk of VTE in malignancy. A reduced level of anticoagulant protein like antithrombin (AT) will influence both coagulation and angiogenesis, as its cleaved and latent conformations show potent antiangiogenic activity. We show a concentration dependent perturbation in the secondary and tertiary structures of AT conformers exposed to hypochlorous acid (HOCl). Modulated under a very narrow concentration range of HOCl, native AT undergoes oligomerization, aggregation and fragmentation based on spectroscopic, SDS and native-PAGE studies. Factor Xa inhibition assay demonstrated a progressive decrease in inhibition activity of AT on modification by HOCl. Bis-ANS result showed that hydrophobic patches were more exposed in the case of HOCl-modified AT when assessed fluorometrically. Dosage of HOCl-modified AT in experimental animals induced high titer antibodies showing more specificity towards modified forms in comparison to unmodified forms. Auto-antibodies isolated from cancer patients also showed enhanced binding with HOCl-modified AT in comparison to native AT. Compared to normal AT, structurally and functionally altered conformation of HOCl modified AT showed increased immunogenic sensitivity. HOCl modified AT can contribute to prothrombotic and angiogenic environment during cancer progression/development.
PMID: 32194043 [PubMed - as supplied by publisher]
13:17
Photo
Not included, change data exporting settings to download.
256×256, 6.0 KB
13:17
In reply to this message
pubmed: caandvteortroorpul
The gut microbiome and thromboembolism.
Related Articles
The gut microbiome and thromboembolism.
Thromb Res. 2020 Mar 06;189:77-87
Authors: Hasan RA, Koh AY, Zia A
No comments:
Post a Comment
اكتب تعليق حول الموضوع